FDA Suspects Falsified Antimalarial Drug On Ghanaian Market
Sunyani February 22, 2023
The Food and Drugs Authority (FDA) says it has suspected falsified antimalarial drug on the Ghanaian market.
The FDA therefore wishes to inform health workers and the general public to be on the lookout and report to the Authority the presence of this particular antimalarial drug- Combiart Tablets with the aforementioned details.
The FDA as part of its market surveillance activities wishes to bring to the attention of health workers and the public, the presence of falsified (counterfeit) antimalarial drug- COMBIART Tablets (Artemether/Lumefantrine 20/120) on our market.
Samples of this drug from the Northern Region did not contain any of the two active pharmaceutical ingredients stated on the label, hence can be classified as falsified.
Writer’s email: firstname.lastname@example.org